Zelira Therapeutics (ASX:ZLD), a company focused on the development of clinically validated cannabis medicines, has appointed Tim Slate as a non-executive director.
Mr Slate was appointed company secretary on 16 December 2016. The company said he provides accounting, secretarial and corporate advice to a number of private and public companies. He has over 15 years experience, is an Associate Member of the Governance Institute of Australia and is a Graduate of the Australian Institute of Company Directors.
The company also announced that Jason Peterson has resigned as a non-executive director effective. Mr Peterson will continue in his role as Corporate Advisor to the Company through CPS Capital Group.
"The Board wishes to thank Mr Peterson for his significant contribution to the Company and wish him all the best with his future endeavours," said the company.